CORVEL CORP (CRVL)
US2210061097 - Common Stock
Overall CRVL gets a fundamental rating of 6 out of 10. We evaluated CRVL against 108 industry peers in the Health Care Providers & Services industry. CRVL gets an excellent profitability rating and is at the same time showing great financial health properties. CRVL has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CRVL was profitable.
In the past year CRVL had a positive cash flow from operations.
In the past 5 years CRVL has always been profitable.
CRVL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CRVL has a better Return On Assets (15.72%) than 97.22% of its industry peers.
CRVL has a better Return On Equity (28.83%) than 95.37% of its industry peers.
The Return On Invested Capital of CRVL (26.38%) is better than 99.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRVL is significantly above the industry average of 8.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.72% | ||
| ROE | 28.83% | ||
| ROIC | 26.38% |
ROA(3y)16.54%
ROA(5y)14.39%
ROE(3y)31.63%
ROE(5y)28.19%
ROIC(3y)28.37%
ROIC(5y)24.01%
1.3 Margins
The Profit Margin of CRVL (9.64%) is better than 93.52% of its industry peers.
CRVL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.02%, CRVL belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
CRVL's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 21.81%, CRVL perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
CRVL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.02% | ||
| PM (TTM) | 9.64% | ||
| GM | 21.81% |
OM growth 3Y3.73%
OM growth 5Y2.98%
PM growth 3Y4.52%
PM growth 5Y4.11%
GM growth 3Y-1.17%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
CRVL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CRVL has been reduced compared to 1 year ago.
Compared to 5 years ago, CRVL has less shares outstanding
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CRVL has an Altman-Z score of 20.00. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.
CRVL has a Altman-Z score of 20.00. This is amongst the best in the industry. CRVL outperforms 98.15% of its industry peers.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 20 |
ROIC/WACC2.86
WACC9.21%
2.3 Liquidity
A Current Ratio of 1.71 indicates that CRVL should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.71, CRVL is doing good in the industry, outperforming 62.04% of the companies in the same industry.
CRVL has a Quick Ratio of 1.71. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CRVL (1.71) is better than 64.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.67%, which is quite good.
CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.40% yearly.
CRVL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.66%.
The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)9.67%
EPS 3Y19.9%
EPS 5Y12.4%
EPS Q2Q%17.33%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y12.9%
Revenue growth 5Y5.95%
Sales Q2Q%14.77%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 73.56, the valuation of CRVL can be described as expensive.
CRVL's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CRVL to the average of the S&P500 Index (27.20), we can say CRVL is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.56 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CRVL's Enterprise Value to EBITDA is on the same level as the industry average.
CRVL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 81.3 | ||
| EV/EBITDA | 44.65 |
4.3 Compensation for Growth
CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.93
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRVL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CORVEL CORP
NASDAQ:CRVL (12/20/2024, 8:04:02 PM)
After market: 345.72 0 (0%)345.72
+11.47 (+3.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.92%
Inst Owner Change0.64%
Ins Owners9.67%
Ins Owner Change-0.92%
Market Cap5.92B
Analysts0
Price TargetN/A
Short Float %4.26%
Short Ratio10.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.56 | ||
| Fwd PE | N/A | ||
| P/S | 7 | ||
| P/FCF | 81.3 | ||
| P/OCF | 55.16 | ||
| P/B | 20.94 | ||
| P/tB | 24.14 | ||
| EV/EBITDA | 44.65 |
EPS(TTM)4.7
EY1.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.25
FCFY1.23%
OCF(TTM)6.27
OCFY1.81%
SpS49.37
BVpS16.51
TBVpS14.32
PEG (NY)N/A
PEG (5Y)5.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.72% | ||
| ROE | 28.83% | ||
| ROCE | 33.26% | ||
| ROIC | 26.38% | ||
| ROICexc | 48.2% | ||
| ROICexgc | 62.08% | ||
| OM | 12.02% | ||
| PM (TTM) | 9.64% | ||
| GM | 21.81% | ||
| FCFM | 8.61% |
ROA(3y)16.54%
ROA(5y)14.39%
ROE(3y)31.63%
ROE(5y)28.19%
ROIC(3y)28.37%
ROIC(5y)24.01%
ROICexc(3y)45.01%
ROICexc(5y)39.5%
ROICexgc(3y)59.7%
ROICexgc(5y)53.06%
ROCE(3y)35.76%
ROCE(5y)30.27%
ROICexcg growth 3Y1.93%
ROICexcg growth 5Y-3.25%
ROICexc growth 3Y6.16%
ROICexc growth 5Y0.55%
OM growth 3Y3.73%
OM growth 5Y2.98%
PM growth 3Y4.52%
PM growth 5Y4.11%
GM growth 3Y-1.17%
GM growth 5Y0.6%
F-Score6
Asset Turnover1.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 123.9% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 82.89% | ||
| Profit Quality | 89.35% | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 20 |
F-Score6
WACC9.21%
ROIC/WACC2.86
Cap/Depr(3y)113.61%
Cap/Depr(5y)111.61%
Cap/Sales(3y)3.98%
Cap/Sales(5y)4.11%
Profit Quality(3y)77.47%
Profit Quality(5y)100.18%
High Growth Momentum
Growth
EPS 1Y (TTM)9.67%
EPS 3Y19.9%
EPS 5Y12.4%
EPS Q2Q%17.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.66%
Revenue growth 3Y12.9%
Revenue growth 5Y5.95%
Sales Q2Q%14.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.13%
EBIT growth 3Y17.12%
EBIT growth 5Y9.11%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.3%
FCF growth 3Y-3.19%
FCF growth 5Y2.01%
OCF growth 1Y49.57%
OCF growth 3Y1.69%
OCF growth 5Y4.76%